Urologic Oncology: Adrenal, Renal, Ureteral, and Retroperitoneal Tumors

Editorial

M Pilar Laguna. J Urol. 2023 Aug.

. 2023 Aug;210(2):377-379.

doi: 10.1097/JU.0000000000003539. Epub 2023 May 18.

No abstract available

Comment on

A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy-A large, retrospective, single-center study.
Rosiello G, Larcher A, Fallara G, Cignoli D, Re C, Martini A, Tian Z, Karakiewicz PI, Mottrie A, Boarin M, Villa G, Trevisani F, Marandino L, Raggi D, Necchi A, Bertini R, Salonia A, Briganti A, Montorsi F, Capitanio U. Rosiello G, et al. Urol Oncol. 2023 Mar;41(3):149.e17-149.e25. doi: 10.1016/j.urolonc.2022.10.008. Epub 2022 Nov 9. Urol Oncol. 2023. PMID: 36369233
International Multi-institutional Characterization of the Perioperative Morbidity of Metastasectomy for Renal Cell Carcinoma.
Lyon TD, Roussel E, Sharma V, Carames G, Lohse CM, Costello BA, Boorjian SA, Thompson RH, Joniau S, Albersen M, Leibovich BC. Lyon TD, et al. Eur Urol Oncol. 2023 Feb;6(1):76-83. doi: 10.1016/j.euo.2022.11.003. Epub 2022 Dec 9. Eur Urol Oncol. 2023. PMID: 36509653